FI67655B - Foerfarande foer behandling av kaseinbaserat material som innehaoller bivalenta katjoner av fosfokaseinater - Google Patents

Foerfarande foer behandling av kaseinbaserat material som innehaoller bivalenta katjoner av fosfokaseinater Download PDF

Info

Publication number
FI67655B
FI67655B FI810174A FI810174A FI67655B FI 67655 B FI67655 B FI 67655B FI 810174 A FI810174 A FI 810174A FI 810174 A FI810174 A FI 810174A FI 67655 B FI67655 B FI 67655B
Authority
FI
Finland
Prior art keywords
ultrafiltration
phosphopeptides
retentate
process according
milk
Prior art date
Application number
FI810174A
Other languages
English (en)
Finnish (fi)
Other versions
FI67655C (fi
FI810174L (fi
Inventor
Gerard Brule
Loic Roger
Jacques Fauquant
Michel Piot
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI810174L publication Critical patent/FI810174L/fi
Application granted granted Critical
Publication of FI67655B publication Critical patent/FI67655B/fi
Publication of FI67655C publication Critical patent/FI67655C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Vacuum Packaging (AREA)
  • Cereal-Derived Products (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Claims (13)

1. Förfarande för behandling av mjölk, mjölkultrafiltrerings-retentat eller isolerade bivalentkatjonfosfokaseinater, säsom t.ex. kalcium- och/eller magnesiumfosfokaseinater, k ä n n e -t e c k n a t därav, att rämaterialet hydrolyseras enzymatiskt i pH-omrädet 7-9 och en temperatur av 37 - 45 °C, med tillhjälp av &tminstone en proteolytisk enzym,s&som pankreatin, trypsin och/eller alfakymotrypsin, som ästadkommer en sädan protein-spjälkning som sker in vivo i människokroppen; det erhällna hyd-rolysatet tillvaratages; nämnda hydrolysat ultrafiltreras &t-minstone en gäng med membraner, som h&ller tillhaka fosfopepti-derna och samtidigt släpper igenom peptiderna, varvid ultrafil-tratet innehäller ofosforyliserade peptider; ultrafiltreringsre-tentatet tillvaratages och de i retentatet befintliga fosfopep-tiderna upplöses; och nämnda retentat ultrafiltreras pä nytt ät-minstone en g&ng med membraner, som icke h&ller tillbaka fosfo-peptider, varvid dessa separerar sig fr&n enzymen och kan tillva-ratagas som produkt.
2. Förfarande enligt patentkrav 1, kännetecknat därav, att som rämaterial användes ett geronmjölkultrafiltrering er-hället retentat i ett koncentrationsförhällande av 1,5 - 3» före-trädesvis ca 2, varvid nämnda ultrafiltreringsskede eventuellt ef-terföljes av ett diafiltreringsskede.
3. Förfarande enligt patentkrav 1 eller 2, kännetecknat därav, att nämnda enzymatiska hydrolys utföres i en anord-ning, där ultrafiltreringsanordningarna ansluter sig tili en en-zymatisk reaktor, varvid bildas en membranförsedd enzymatisk reak-tor.
4. Förfarande-enligt patentkrav 3, kännetecknat därav, att den enzymatiska hydrolysen utföres kontinuerligt»genom att mata kaseinbaserat rämaterial tili reaktionsomr&det för att kraf-tigt bringa det i kontakt med enzymet, reaktionsprodukten avlägs-nas kontinuerligt genom att förflytta den fr&n reaktionsomr&det 33 67655 till ultrefiltreringsomrädet, varifrän likasä kontinuerligt av-lägsnas permeat, som bildar ett peptidiskt hydrolysat.
5« Förfarande enligt nägot av patentkraven 1-4, kanne -t e c k n a t därav, att pH regleras tili omrädet 7 - 8,5, t.ex. tili ett värde av ca 8 under nämnda enzymatiska hydrolys.
6. Förfarande enligt nägot av patentkraven 1-5, k ä n n e -t e c k n a t därav, att som enzym användes pankreatin i form av ett naturligt pankreatinextrakt eller syntetiska blandningar av trypsin ooh alfakymotrypsin.
7. Förfarande enligt nägot av patentkraven 1-6, kanne-t e c k n a t därav, att hydrolystemperaturen hälles i omrädet 37 - 40°C, företrädesvis vid ett värde av ca 37°C.
8. Förfarande enligt nägot av patentkraven 1-7, känne- t e c k n a t därav, att i de n enzymatiska reaktorn av membran-typ utnyttjas membraner, vilka är i ständ att hindra enzymet frän att passera igenom.
9. Förfarande enligt nägot av patentkraven 1-8, känne- t e c k n a t därav, att efter nämnda hydrolys den i den enzymatiska reaktorn äterstäende lösningen ultrafiltreras med membraner, vilka häller tillbaka fosfopeptiderna och genomsläpper de ofosfo-ryliserade peptiderna, varvid membranernas isoleringströskel är i omrädet ca 2000 - 50,000.
10. Förfarande enligt patentkrav 9, kännetecknat därav, att nämnda ultrafiltrering efterföljes av ett diafiltre-ringsskede för att tömma den ofosforyliserade peptidiska fraktio-nen, genom att tili den i kontakt med membranen försatta produk-ten tillsätta antingen vatten eller salthaltig vattenlösning eller företrädesvis mjölkultraflitrat, vara pH höjts tili ett värde av ca 7 - 8.
11. Förfarande enligt nägot av patentkraven 1-10, kännetecknat därav, att upplösningen av de i retentatet befint-
FI810174A 1980-02-01 1981-01-22 Foerfarande foer behandling av kaseinbaserat material som innehaoller bivalenta katjoner av fosfokaseinater FI67655C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8002280 1980-02-01
FR8002280A FR2474828B1 (fr) 1980-02-01 1980-02-01 Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application

Publications (3)

Publication Number Publication Date
FI810174L FI810174L (fi) 1981-08-02
FI67655B true FI67655B (fi) 1985-01-31
FI67655C FI67655C (fi) 1985-05-10

Family

ID=9238131

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810174A FI67655C (fi) 1980-02-01 1981-01-22 Foerfarande foer behandling av kaseinbaserat material som innehaoller bivalenta katjoner av fosfokaseinater

Country Status (13)

Country Link
US (3) US4361587A (sv)
EP (1) EP0033686B1 (sv)
JP (3) JPS56123921A (sv)
AT (1) ATE10330T1 (sv)
AU (1) AU548657B2 (sv)
CA (1) CA1165711A (sv)
DE (1) DE3167245D1 (sv)
DK (1) DK42781A (sv)
ES (1) ES8201407A1 (sv)
FI (1) FI67655C (sv)
FR (1) FR2474828B1 (sv)
NO (1) NO151442C (sv)
ZA (1) ZA81590B (sv)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216123A (en) * 1980-02-01 1993-06-01 Institut National De La Recherche Agronomique Non-phosphorylated peptides from casein-based material
US5219735A (en) * 1980-02-01 1993-06-15 Institut National De La Recherche Agronomique Non-phosphorylated peptides from casein-based material
US5334408A (en) * 1980-02-01 1994-08-02 Institut National De La Recherche Agronomique Nutrient composition containing non-phosphorylated peptides from casin-based material
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
ES8105392A1 (es) * 1980-06-16 1981-06-01 Tena Guillermo Procedimiento de obtencion de una solucion de aminoacidos y peptidos de origen animal por proceso enzimatico
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
JPS59162843A (ja) * 1983-03-08 1984-09-13 Meiji Seika Kaisha Ltd 鉄吸収効率の高い飲食物
US5298493A (en) * 1983-04-20 1994-03-29 Clintec Nutrition Co. Compound for use in dietetics, reanimation and therapeutics containing protein fractions based on three types of minipeptides
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
US4668772A (en) * 1984-11-27 1987-05-26 Nestec S.A. Methods for controlling the viscosity of protein hydrolysates
JPH0739351B2 (ja) * 1985-06-01 1995-05-01 森永乳業株式会社 家畜又はペットの水摂取意欲を旺盛にし飲水量を増大する方法
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability
JPH01285158A (ja) * 1988-05-12 1989-11-16 Itochu Shiryo Kk 家禽用飼料
US5006472A (en) * 1988-06-03 1991-04-09 Miles Inc. Enzymatic purification process
JPH0283333A (ja) * 1988-09-21 1990-03-23 Snow Brand Milk Prod Co Ltd 鉄カゼインを有効成分とする鉄欠乏性貧血治療用組成物
JPH02268649A (ja) * 1989-04-08 1990-11-02 Kanebo Ltd ペプチド混合物、その製造方法およびそれを含有せしめた食品
FR2650955B1 (fr) * 1989-08-16 1992-01-10 Agronomique Inst Nat Rech Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
US5290685A (en) * 1990-02-22 1994-03-01 Meiji Milk Products Company Limited Method for separation and concentration of phosphopeptides
EP0457565B1 (en) * 1990-05-18 1997-07-30 Morinaga Milk Industry Co., Ltd. Milk-protein hydrolyzates and compositions for use as hair and skin treating agent
NL9001650A (nl) * 1990-07-19 1992-02-17 Ver Coop Melkind Werkwijze voor de bereiding van een melkeiwit-isolaat.
WO1994012524A1 (en) * 1992-11-30 1994-06-09 Celsus, Inc. Protein hydrolysate derived from mucosal tissue
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
DE4429558A1 (de) * 1994-08-19 1996-02-22 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung von infektionsfreien pharmazeutischen Präparaten und/oder Nahrungsmitteln aus infektiösem Material
US5639501A (en) * 1995-01-31 1997-06-17 Vembu; Rajan Separation of minerals from whey permeate
JP3694871B2 (ja) * 1996-10-18 2005-09-14 日鉄化工機株式会社 目的成分の分離・回収方法
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US6051687A (en) * 1999-02-22 2000-04-18 Nutra-Flo Company Purification of liquid protein hydrolysate and the resultant products
US6372354B1 (en) * 1999-09-13 2002-04-16 Chemat Technology, Inc. Composition and method for a coating providing anti-reflective and anti-static properties
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
CA2353307A1 (fr) * 2001-07-13 2003-01-13 Carmen Parent Appareil et procede pour le traitement des effluents gazeux
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
DK1545235T3 (da) 2002-07-29 2014-01-27 Zymtech Production As Fremgangsmåde til fremstilling af peptider og aminosyrer fra proteinholdigt materiale af animalsk oprindelse
JP5204947B2 (ja) 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
US7118772B2 (en) * 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
US7183507B2 (en) * 2005-01-20 2007-02-27 Susan Simoneau Appliance having a timer
PE20121730A1 (es) * 2010-01-29 2013-01-13 Abbott Lab Liquidos nutricionales envasados asepticamente que comprenden beta-hidroxi-beta-metilbutirato (hmb)
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US20220232838A1 (en) * 2019-04-15 2022-07-28 Basf Se Whipping agent for baked goods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857966A (en) * 1973-08-16 1974-12-31 Gen Foods Corp Process for bland, soluble protein
US3970520A (en) * 1973-09-17 1976-07-20 General Foods Corporation Nutritionally improved foodstuffs
DE2405589C3 (de) * 1974-02-06 1980-08-07 Agfa-Gevaert Ag, 5090 Leverkusen Verfahren zur Herstellung leicht benetzbarer, wasserlöslicher natürlicher Eiweißprodukte
FR2292435A1 (fr) * 1974-11-29 1976-06-25 Agronomique Inst Nat Rech Procede de traitement de matieres contenant des proteines, telles que le lait
FR2399213A1 (fr) * 1977-08-04 1979-03-02 Bertin & Cie Purification de matieres organiques en vue de la production des acides amines
US4172072A (en) * 1977-10-20 1979-10-23 Ashmead H H Buffered enzymatically produced metal proteinates
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
US5216123A (en) * 1980-02-01 1993-06-01 Institut National De La Recherche Agronomique Non-phosphorylated peptides from casein-based material

Also Published As

Publication number Publication date
NO151442C (no) 1985-04-10
NO151442B (no) 1985-01-02
JPH0558691B2 (sv) 1993-08-27
JPH06205645A (ja) 1994-07-26
ZA81590B (en) 1982-02-24
EP0033686B1 (fr) 1984-11-21
FR2474828A1 (fr) 1981-08-07
DK42781A (da) 1981-08-02
US5352476A (en) 1994-10-04
FI67655C (fi) 1985-05-10
ATE10330T1 (de) 1984-12-15
AU548657B2 (en) 1986-01-02
AU6678281A (en) 1981-08-06
ES498962A0 (es) 1981-11-16
DE3167245D1 (en) 1985-01-03
FR2474828B1 (fr) 1983-09-09
US4980450A (en) 1990-12-25
EP0033686A3 (en) 1981-08-26
JP2509436B2 (ja) 1996-06-19
NO810334L (no) 1981-08-03
FI810174L (fi) 1981-08-02
JPH07114634B2 (ja) 1995-12-13
US4361587A (en) 1982-11-30
EP0033686A2 (fr) 1981-08-12
ES8201407A1 (es) 1981-11-16
JPH06205646A (ja) 1994-07-26
JPS56123921A (en) 1981-09-29
CA1165711A (en) 1984-04-17

Similar Documents

Publication Publication Date Title
FI67655C (fi) Foerfarande foer behandling av kaseinbaserat material som innehaoller bivalenta katjoner av fosfokaseinater
FI67656C (fi) Foerfarande foer behandling av monovalenta katjoner av fosfokaseinater och deras derivat
FI68503C (fi) Foerfarande foer framstaellning av enzymatiskt totalhydrolysatav vassleproteiner
JPH05505304A (ja) 酵素加水分解物の製造方法
NZ258207A (en) Whey protein with low phosphorus content
US5436020A (en) Method for producing a formulated milk for infants analogous to human milk
JPS63258599A (ja) ジペプチド及びトリペプチドに富んだ酵素タンパク質加水分解物の製造法
US5219735A (en) Non-phosphorylated peptides from casein-based material
EP0443763A2 (en) Formulated milk for infants analogous to human milk
US5216123A (en) Non-phosphorylated peptides from casein-based material
US5334408A (en) Nutrient composition containing non-phosphorylated peptides from casin-based material
JPH08173052A (ja) 大豆蛋白質の製造法
JP3406367B2 (ja) ミネラル吸収促進効果を有する大豆蛋白質の製造法
CS269496B1 (cs) Způsob výroby enzymových hydrolyzátů;. z mléčných surovin

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CLINTEC NUTRITION COMPANY

MM Patent lapsed
MM Patent lapsed

Owner name: CLINTEC NUTRITION COMPANY